Pretreatment PSA levels affects the completion rate of Ra-223 treatment
Abstract The aim of this study was to review our initial experience of using radium 223 (Ra-223) for metastatic castration-resistant prostate cancer (CRPC) and to evaluate whether pretreatment PSA levels correlate with completion of Ra-223 treatment. In addition, we examined change ratios of PSA, AL...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b21b6bec7d8547c9b0bee33a89f12746 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|